You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscarinic M1 Receptor

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

Recruiting
  • Locally Advanced Gastrointestinal Stromal Tumor
  • +7 more
  • Biopsy
  • +4 more
  • Duarte, California
  • +17 more
Feb 2, 2023

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Trial in Worldwide (AZD9291 80

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
  • AZD9291 80 mg/40 mg + placebo
  • +5 more
  • Anaheim, California
  • +168 more
Nov 29, 2022

Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and

Completed
  • Microsatellite Stable Colorectal Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Solid Tumors Trial (Bemarituzumab)

Recruiting
  • Solid Tumors
  • Duarte, California
  • +54 more
Feb 1, 2023

Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)

Recruiting
  • Post-COVID-19 Syndrome
  • +2 more
  • Immunoadsorption
  • Sham-apheresis
  • Mainz, Rheinland-Pfalz, Germany
    UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
May 2, 2023

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
Has Results
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Healthy Volunteers Trial in Stockholm (AZD2115, SPIRIVA, [11C]AZ13754366)

Completed
  • Healthy Volunteers
  • Stockholm, Sweden
    Research Site
Aug 27, 2021

Bardet Biedl Syndrome (BBS), Alström Syndrome (AS) Trial in Worldwide (Setmelanotide, Placebos)

Completed
  • Bardet Biedl Syndrome (BBS)
  • Alström Syndrome (AS)
  • San Diego, California
  • +11 more
Jul 19, 2021

Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

Completed
  • Cancer
  • +3 more
  • Boston, Massachusetts
  • +12 more
Mar 11, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Louisville, Kentucky
  • +66 more
Nov 9, 2022

Non Small Cell Lung Cancer Trial in China (XZP-5809-TT1 Tablet)

Recruiting
  • Non Small Cell Lung Cancer
  • XZP-5809-TT1 Tablet
  • Beijing, Beijing, China
  • +4 more
Mar 17, 2021

Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • nivolumab
  • +6 more
  • Mobile, Alabama
  • +255 more
Jul 21, 2022

Apparent Life-Threatening Event in Infants Under One Year of Age Trial in France (Blood sample for specific analyzes)

Recruiting
  • Apparent Life-Threatening Event in Infants Under One Year of Age
  • Blood sample for specific analyzes
  • Besançon, France
  • +3 more
Jun 28, 2022

Neovascular Age-Related Macular Degeneration Trial in Shanghai (HB002.1M)

Completed
  • Neovascular Age-Related Macular Degeneration
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Jul 28, 2020

Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)

Recruiting
  • Breast Cancer
  • Non-small Cell Lung Carcinoma
  • San Francisco, California
  • +24 more
Nov 30, 2022

Castration-Resistant Prostatic Tumors Trial in Worldwide (Cetrelimab 480 mg, Apalutamide 240 mg)

Completed
  • Castration-Resistant Prostatic Neoplasms
  • Cetrelimab 480 mg
  • Apalutamide 240 mg
  • San Francisco, California
  • +33 more
Feb 24, 2022

NSCLC Trial in Worldwide (Osimertinib, Pemetrexed/Carboplatin, Pemetrexed/Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Bellflower, California
  • +154 more
Dec 23, 2022

COPD Trial in Groningen, Leeuwarden (Tiotropium Bromide)

Recruiting
  • COPD
  • Tiotropium Bromide
  • Groningen, Netherlands
  • +1 more
Jul 19, 2022

Penehyclidine, Postoperative Nausea and Vomiting, Bimaxillar Surgery Trial in Beijing (Single injection of penehyclidine,

Completed
  • Penehyclidine
  • +2 more
  • Single injection of penehyclidine
  • +2 more
  • Beijing, China
    Peking Univeristy Hospital Stomatology
Sep 14, 2021

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

Advanced or Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Paclitaxel)

Recruiting
  • Advanced or Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Scottsdale, Arizona
  • +343 more
Jul 22, 2022

Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

Recruiting
  • Sjogren's Syndrome
  • Overactive Bladder Syndrome
  • Taichung, Taiwan
    China Medical University Hospital
Aug 8, 2021

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Anchorage, Alaska
  • +55 more
Jul 25, 2022

Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)

Recruiting
  • Breast Neoplasms
  • pembrolizumab
  • +6 more
  • Tucson, Arizona
  • +188 more
Aug 11, 2022

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,

Recruiting
  • Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
  • Anchorage, Alaska
  • +386 more
Jan 30, 2023